Citadel Advisors
LMDXW

Citadel Advisors’s LumiraDx Limited Warrant LMDXW Stock Holding History

Citadel Advisors’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,786
Closed -$2K – 15675
2022
Q3 		$2K Buy
18,786
+616
+3% +$205 ﹤0.01% 12430
2022
Q2 		$16K Sell
18,170
-400
-2% -$346 ﹤0.01% 12481
2022
Q1 		$15K Sell
18,570
-2,861
-13% -$3.68K ﹤0.01% 13317
2021
Q4 		$31K Sell
21,431
-314
-1% -$507 ﹤0.01% 13474
2021
Q3 		$27K Buy
+21,745
New +$25.2K ﹤0.01% 13595

Other funds holding LMDXW

CH
CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CP
Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return

Citadel Advisors's LMDXW Position: Q4 2022 in Review

Citadel Advisors sold out of LumiraDx Limited Warrant (LMDXW) in Q4 2022, closing a stake of 18,786 shares — an estimated $2K sold.

Citadel Advisors first reported a position in LMDXW in Q3 2021 and held it in 5 quarters. The position peaked at $31K in Q4 2021. 17 funds tracked by Wall St. Rank hold LMDXW as of Q4 2022.

  • Citadel Advisors reported no remaining LumiraDx Limited Warrant position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 18,786 LumiraDx Limited Warrant shares in Q4 2022, an estimated $2K.
  • Citadel Advisors first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 5 quarters.
  • Citadel Advisors's LumiraDx Limited Warrant position peaked at $31K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.